Healthcare provider profile · identity verified

Jay Richard Seidler, DO

Family Practice · MOUNT AIRY, NC · NPI 1962407254

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	499	103
Amlodipine Besylate	Amlodipine Besylate	490	113
Atorvastatin Calcium	Atorvastatin Calcium	469	118
Metformin Hcl	Metformin Hcl	403	94
Lisinopril	Lisinopril	324	91
Omeprazole	Omeprazole	292	81
Metoprolol Succinate	Metoprolol Succinate	260	67
Pantoprazole Sodium	Pantoprazole Sodium	250	57
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	238	62
Pravastatin Sodium	Pravastatin Sodium	232	59
Losartan Potassium	Losartan Potassium	225	58
Hydrochlorothiazide	Hydrochlorothiazide	192	48
Lorazepam	Lorazepam	187	29
Rosuvastatin Calcium	Rosuvastatin Calcium	183	54
Furosemide	Furosemide	179	55
Gabapentin	Gabapentin	178	52
Montelukast Sodium	Montelukast Sodium	172	40
Alprazolam	Alprazolam	167	38
Allopurinol	Allopurinol	164	36
Glimepiride	Glimepiride	149	37
Tamsulosin Hcl	Tamsulosin Hcl	144	38
Escitalopram Oxalate	Escitalopram Oxalate	137	35
Metoprolol Tartrate	Metoprolol Tartrate	136	28
Prednisone	Prednisone	136	78
Meloxicam	Meloxicam	135	58
Tramadol Hcl	Tramadol Hcl	128	36
Famotidine	Famotidine	125	31
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	119	27
Citalopram Hbr	Citalopram Hydrobromide	116	30
Carvedilol	Carvedilol	115	31
Duloxetine Hcl	Duloxetine Hcl	112	28
Ezetimibe	Ezetimibe	112	34
Sertraline Hcl	Sertraline Hcl	110	23
Lovastatin	Lovastatin	109	27
Albuterol Sulfate Hfa	Albuterol Sulfate	105	33
Fluticasone Propionate	Fluticasone Propionate	104	38
Eliquis	Apixaban	103	23
Zolpidem Tartrate	Zolpidem Tartrate	103	22
Venlafaxine Hcl Er	Venlafaxine Hcl	97	27
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	88	19
Trazodone Hcl	Trazodone Hcl	88	25
Alendronate Sodium	Alendronate Sodium	87	26
Ropinirole Hcl	Ropinirole Hcl	87	16
Simvastatin	Simvastatin	85	20
Bupropion Xl	Bupropion Hcl	77	19
Mirtazapine	Mirtazapine	73	21
Clopidogrel	Clopidogrel Bisulfate	70	18
Buspirone Hcl	Buspirone Hcl	68	13
Finasteride	Finasteride	68	16
Potassium Chloride	Potassium Chloride	68	23
Fluoxetine Hcl	Fluoxetine Hcl	62	16
Clonazepam	Clonazepam	60	12
Tizanidine Hcl	Tizanidine Hcl	60	33
Pioglitazone Hcl	Pioglitazone Hcl	57	15
Esomeprazole Magnesium	Esomeprazole Magnesium	52	suppressed
Memantine Hcl	Memantine Hcl	48	11
Olmesartan Medoxomil	Olmesartan Medoxomil	48	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	47	14
Meclizine Hcl	Meclizine Hcl	45	21
Metformin Hcl Er	Metformin Hcl	45	12
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	45	suppressed
Jardiance	Empagliflozin	43	suppressed
Pregabalin	Pregabalin	43	12
Xarelto	Rivaroxaban	43	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	41	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	41	23
Cephalexin	Cephalexin	40	35
Oxycodone Hcl	Oxycodone Hcl	38	suppressed
Mounjaro	Tirzepatide	35	suppressed
Paroxetine Hcl	Paroxetine Hcl	33	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	29	suppressed
Azithromycin	Azithromycin	29	21
Warfarin Sodium	Warfarin Sodium	29	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	28	26
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	27	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	25	11
Doxycycline Hyclate	Doxycycline Hyclate	25	24
Paxlovid	Nirmatrelvir/Ritonavir	25	25
Spironolactone	Spironolactone	25	suppressed
Benazepril Hcl	Benazepril Hcl	24	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	23	suppressed
Glipizide	Glipizide	23	suppressed
Naproxen	Naproxen	23	suppressed
Dexlansoprazole Dr	Dexlansoprazole	22	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	22	suppressed
Diclofenac Sodium	Diclofenac Sodium	21	suppressed
Diltiazem Hcl	Diltiazem Hcl	21	suppressed
Humulin N	Insulin Nph Human Isophane	21	suppressed
Lamotrigine	Lamotrigine	21	suppressed
Irbesartan	Irbesartan	20	suppressed
Nystatin	Nystatin	20	12
Synthroid	Levothyroxine Sodium	20	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	19	suppressed
Fluconazole	Fluconazole	19	15
Januvia	Sitagliptin Phosphate	19	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	19	suppressed
Atenolol	Atenolol	18	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	18	suppressed
Doxepin Hcl	Doxepin Hcl	18	suppressed
Entresto	Sacubitril/Valsartan	18	suppressed
Hydralazine Hcl	Hydralazine Hcl	18	suppressed
Sildenafil Citrate	Sildenafil Citrate	18	suppressed
Spiriva Handihaler	Tiotropium Bromide	18	suppressed
Clonidine Hcl	Clonidine Hcl	17	suppressed
Temazepam	Temazepam	17	suppressed
Tresiba Flextouch U-100	Insulin Degludec	17	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	17	suppressed
Breo Ellipta	Fluticasone/Vilanterol	16	suppressed
Clobetasol Propionate	Clobetasol Propionate	16	suppressed
Fenofibrate	Fenofibrate	16	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	16	suppressed
Ozempic	Semaglutide	16	suppressed
Chlorthalidone	Chlorthalidone	15	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	15	15
Ipratropium Bromide	Ipratropium Bromide	15	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	15	suppressed
Benztropine Mesylate	Benztropine Mesylate	13	suppressed
Bupropion Hcl Sr	Bupropion Hcl	13	suppressed
Divalproex Sodium Er	Divalproex Sodium	13	suppressed
Glipizide Er	Glipizide	13	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Ondansetron Hcl	Ondansetron Hcl	13	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	13	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	13	suppressed
Ventolin Hfa	Albuterol Sulfate	13	suppressed
Bumetanide	Bumetanide	12	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Sotalol	Sotalol Hcl	12	suppressed
Topiramate	Topiramate	12	suppressed
Unifine Pentips Plus	Pen Needle, Diabetic	12	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	11	suppressed
Enalapril-Hydrochlorothiazide	Enalapril/Hydrochlorothiazide	11	suppressed
Estradiol	Estradiol	11	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	11	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	11
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	11	suppressed
Promethazine Hcl	Promethazine Hcl	11	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	11	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	11	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error